165 filings
424B3
TLSI
TriSalus Life Sciences Inc
7 May 24
Prospectus supplement
4:08pm
424B3
TLSI
TriSalus Life Sciences Inc
7 May 24
Prospectus supplement
4:04pm
8-K
TLSI
TriSalus Life Sciences Inc
7 May 24
Departure of Directors or Certain Officers
4:01pm
424B3
TLSI
TriSalus Life Sciences Inc
30 Apr 24
Prospectus supplement
5:02pm
424B3
TLSI
TriSalus Life Sciences Inc
30 Apr 24
Prospectus supplement
5:01pm
8-K
kownfiu1c1cuhg4 dfw
30 Apr 24
TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNavĀ® Infusion System Growth Initiatives
5:00pm
EFFECT
s99nu560os4by3
25 Apr 24
Notice of effectiveness
12:15am
EFFECT
tbw 7g8j9ttyt
25 Apr 24
Notice of effectiveness
12:15am
POS AM
2nxij 71a0fwcbsjeho
16 Apr 24
Prospectus update (post-effective amendment)
6:36pm
POS AM
els bjc1c37uejt7y8
16 Apr 24
Prospectus update (post-effective amendment)
6:31pm
8-K
pzu4tddt6l i92ysq
15 Apr 24
Changes in Registrant's Certifying Accountant
5:43pm
S-8
qmide1v8m5yfezi gb
11 Apr 24
Registration of securities for employees
5:14pm
NT 10-K
5myudbi iotphlns6xb4
2 Apr 24
Notice of late annual filing
6:07am
8-K
0lb27rq9
1 Apr 24
TriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update
8:05am
8-K
21e6vwqa1
11 Mar 24
Results of Operations and Financial Condition
9:25pm
424B3
s8vnutuav
25 Jan 24
Prospectus supplement
5:23pm
424B3
z71b3
25 Jan 24
Prospectus supplement
5:21pm
8-K
ort fqm2ilvb2p
25 Jan 24
Departure of Directors or Certain Officers
5:19pm
8-K
m1gerviw6brco
5 Jan 24
Results of Operations and Financial Condition
4:28pm